Valeant continues Russian spending spree with $180m Natur Produkt buy

Valeant Pharmaceuticals International Inc. saw its stock price tick up slightly after announcing its $180 million purchase of Russian over-the-counter cold remedy company Natur Produkt.

Valeant Pharmaceuticals International Inc. saw its stock price tick up slightly after announcing its $180 million purchase of Russian over-the-counter cold remedy company Natur Produkt.

Valeant’s stock closed 1.6 percent higher at $54.61 on 26 March, compared to $53.75 per share on 23 March, after...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Alimentary/Metabolic

More from Therapeutic Category